Products

Learn about Docetere Injection 20 mg/0.5 ml, containing Docetaxel 20 mg, an anticancer chemotherapy medicine used under medical supervision. Read product profile, indications, mechanism, administration, safety, storage, documentation, and country-wise information for Washington, London, Riyadh, Canberra, UAE, and Kingston Jamaica. Docetere Injection 20 mg/0.5 ml – Docetaxel 20 mg Chemotherapy Injection for Oncology Care Docetere Injection 20 mg Product Name: Docetere Injection 20 mg/0.5 ml Generic Name: Docetaxel Strength: 20 mg Dosage Form: Injection / Concentrate for IV Infusion Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Chemotherapy Medicine Use: Used in oncology treatment under the guidance of a qualified cancer specialist Administration Route: Intravenous infusion only Prescription Status: Prescription-only oncology medicine Docetere Injection 20 mg contains Docetaxel, a chemotherapy medicine used in cancer treatment protocols. It belongs to a group of anticancer medicines known as taxanes. Docetaxel works by interfering with cancer cell division and is used only under the supervision of trained healthcare professionals. This medicine is not suitable for self-use. It must be prepared, diluted, administered, monitored, and disposed of according to hospital oncology protocols. Step 1: What Is Docetere Injection 20 mg? Docetere Injection 20 mg is an injectable chemotherapy medicine containing Docetaxel 20 mg. It is supplied in a single vial and is used as part of cancer treatment plans prescribed by oncologists. Docetaxel may be used alone or in combination with other anticancer medicines depending on the type of cancer, stage of disease, previous treatment history, body surface area, blood count, liver function, and overall patient condition. Step 2: Clinical Indications & Usage Docetaxel is used in oncology care for selected cancer types. Depending on the approved label, hospital protocol, and doctor’s decision, it may be considered in treatment plans for: Breast Cancer Docetaxel may be used in locally advanced or metastatic breast cancer and in some adjuvant treatment combinations. Non-Small Cell Lung Cancer It may be used in certain patients with locally advanced or metastatic non-small cell lung cancer. Prostate Cancer Docetaxel is used in selected prostate cancer treatment protocols, often with other supportive medicines as directed by the oncologist. Gastric Cancer It may be included in specific chemotherapy combinations for advanced gastric cancer. Head and Neck Cancer Docetaxel may be used in certain head and neck cancer protocols as part of combination therapy. Important: The exact use depends on the doctor’s prescription, local regulatory approval, cancer type, treatment line, and patient health status. Step 3: Mechanism of Action – How Docetere Injection Works Docetere Injection contains Docetaxel, which is a taxane chemotherapy agent. Cancer cells grow and divide rapidly. Docetaxel works by disturbing the internal structure needed for cell division. In simple words: Cancer cells need microtubules to divide. Docetaxel affects microtubule function. This prevents cancer cells from dividing normally. As a result, cancer cell growth may slow down or stop. The damaged cancer cells may then die. This action makes Docetaxel useful in chemotherapy treatment plans. However, because chemotherapy can also affect some normal fast-growing cells, side effects may occur and regular monitoring is necessary. Step 4: Administration and Dosing Guide Docetere Injection 20 mg should be administered only by trained healthcare professionals in a hospital, cancer center, or oncology day-care unit. General Administration Points Route: Intravenous infusion only Use: Under oncologist supervision Preparation: Dilution and preparation must follow product label and hospital protocol Dose: Usually calculated based on body surface area and clinical condition Why Choose Primecare Impex Primecare Impex provides pharmaceutical product information and export support for healthcare-related requirements from India. The focus is on genuine product communication, proper documentation, clear product details, and professional support. Primecare Impex Highlights Pharmaceutical exporter from India Product information support Oncology medicine category experience Documentation support where applicable Clear communication for international enquiries Support for product profile, packing, strength, and availability details Professional handling of medicine-related enquiries 📞 Contact Primecare Impex — Pharmaceutical Exporter from India For product profile details, availability information, documentation support, and enquiry assistance: Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Docepar Injection 80 mg, 120 mg & 20 mg – Docetaxel Injection Supplier from India | Primecare Impex Docepar Injection contains Docetaxel, an anti-cancer medicine used in chemotherapy treatment plans. Available in 80 mg/2 ml, 20 mg/0.5 ml and 120 mg/3 ml vial strengths. Contact Primecare Impex, pharmaceutical exporter from India. Docepar Injection – Docetaxel Injection 80 mg/2 ml, 20 mg/0.5 ml & 120 mg/3 ml for Oncology Care Understanding Docepar Injection Product Name: Docepar Injection Generic Composition: Docetaxel Injection Available Strengths: Docepar Injection 20 mg/0.5 ml Docepar Injection 80 mg/2 ml Docepar Injection 120 mg/3 ml Packing Size: 1 Vial Therapeutic Category: Anti-cancer Medicine / Oncology Medicine Dosage Form: Injection Route of Use: Intravenous infusion under medical supervision Use: Anti-cancer medicine used as part of chemotherapy treatment plans Docepar Injection is a Docetaxel-based chemotherapy medicine used in oncology treatment. Docetaxel belongs to the taxane class of anti-cancer medicines and is used by healthcare professionals in the management of several cancer conditions depending on the patient’s diagnosis, treatment stage, body surface area, previous therapy, and oncologist’s prescription. Docepar Injection is available in multiple strengths, including 20 mg/0.5 ml, 80 mg/2 ml and 120 mg/3 ml, allowing oncology teams to select the appropriate vial strength according to the prescribed chemotherapy dose. It is intended only for hospital, cancer-care center, chemotherapy daycare, or licensed clinical use. Docetaxel Injection may be used in treatment plans for different types of cancer as decided by an oncologist. It is commonly associated with oncology protocols for: Breast cancer Non-small cell lung cancer Prostate cancer Gastric cancer Head and neck cancer The exact use depends on the patient’s condition, previous treatment history, cancer type, stage of disease, and the treating doctor’s clinical decision. How Docepar Injection Works Docepar Injection contains Docetaxel, a taxane anti-cancer agent. Docetaxel works by interfering with microtubule function inside cancer cells. Microtubules are important for cell division. By stabilizing microtubules and preventing their normal breakdown, Docetaxel disrupts cancer cell division and slows the growth of rapidly multiplying cancer cells. Because chemotherapy medicines can also affect normal fast-dividing cells, patients may experience side effects. This is why Docetaxel therapy requires blood tests, medical review, and monitoring during the treatment cycle. Docepar Injection 20 mg/0.5 ml Docepar Injection 80 mg/2 ml Docepar Injection 120 mg/3 ml Composition should be checked as Docetaxel Injection with the required vial strength. Docetaxel Injection is a prescription oncology medicine. It should be used only in a licensed medical or oncology setup. Docetaxel Injection exporter from India Docepar Injection supplier from India Oncology medicine exporter Primecare Impex Anti-cancer injection supplier from India Chemotherapy medicine export service Docetaxel Injection 80 mg vial supplier Docepar Injection 120 mg vial information Prescription oncology medicine exporter What is Docepar Injection? Docepar Injection is a Docetaxel-based anti-cancer medicine used in chemotherapy treatment under oncologist supervision. The packing size is 1 vial. Yes, it contains Docetaxel, an anti-cancer medicine used in oncology treatment protocols. What cancers is Docetaxel used for? Docetaxel may be used in treatment plans for breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer, depending on the doctor’s prescription. Why Choose Primecare Impex? Primecare Impex is a pharmaceutical exporter, supplier, and distributor from India supporting international inquiries for prescription oncology medicines, including Docetaxel Injection products such as Docepar Injection. Primecare Impex focuses on: Oncology medicine export support Product availability assistance Documentation support Export packing guidance Prescription medicine handling awareness Country-wise shipment coordination Professional communication for healthcare-related inquiries All prescription medicines are supplied according to applicable regulatory requirements, documentation, and buyer eligibility. Contact Primecare Impex – Pharmaceutical Exporter from India Company Name: Primecare Impex Business Type: Exporter | Supplier | Distributor Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 For Docepar Injection 20 mg/0.5 ml, 80 mg/2 ml or 120 mg/3 ml product inquiries, contact Primecare Impex with required strength, quantity, destination country, and documentation requirement. Looking for Docepar Injection 80 mg, 120 mg or 20 mg product information? Contact Primecare Impex for Docetaxel Injection availability, export documentat

Cytosar Injection 1000 mg | Cytarabine 1000 mg in 10 ml Information Guide Learn about Cytosar Injection 1000 mg, containing Cytarabine 1000 mg in 10 ml. Explore its clinical use, mechanism, administration overview, safety monitoring, storage, and regulatory documentation guidance. Cytosar Injection 1000 mg – Cytarabine 1000 mg in 10 ml Anticancer Injection Information Cytosar Injection 1000 mg Product Name: Cytosar Injection 1000 mg Generic Name: Cytarabine Strength: Cytarabine 1000 mg in 10 ml Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Antineoplastic Agent Dosage Form: Injection Use: Used in selected cancer treatment protocols under specialist medical supervision Cytosar Injection 1000 mg contains Cytarabine, a chemotherapy medicine used in hospital-based oncology and hematology treatment settings. Cytarabine belongs to the antimetabolite class of anticancer medicines and is commonly associated with treatment protocols for certain blood cancers, especially acute leukemia. This injection should only be administered by trained healthcare professionals. It is not suitable for self-use, home use without medical supervision, or non-prescription use. The dose, route, dilution, schedule, and monitoring plan are decided by an oncologist or hematologist based on the patient’s diagnosis, body surface area, treatment protocol, blood counts, kidney/liver function, and overall health condition. Cytosar Injection 1000 mg is used in oncology treatment protocols where Cytarabine is clinically appropriate. Cytarabine is mainly used for induction and maintenance of remission in acute leukemia. It may also be used in certain other leukemia or lymphoma-related treatment plans when prescribed by a specialist. Where Cytarabine May Be Used Acute Myeloid Leukemia Cytarabine is widely known as a key medicine in many AML treatment protocols. It may be used during induction therapy, consolidation therapy, or other protocol-based regimens. Acute Lymphocytic Leukemia In selected treatment protocols, Cytarabine may be included as part of combination chemotherapy. Meningeal Leukemia Certain preservative-free Cytarabine formulations may be used intrathecally in specific cases under strict hospital supervision. Other Hematologic Malignancies Cytarabine may be included in selected specialist-managed regimens for blood-related cancers depending on the patient’s condition and treatment plan. How Cytosar Works Cytarabine is an antimetabolite chemotherapy medicine. It interferes with DNA synthesis in rapidly dividing cells. Cancer cells, especially leukemia cells, divide quickly and depend on DNA replication for growth and survival. After entering the body, Cytarabine is converted inside cells into its active form. This active form blocks DNA polymerase activity and interferes with DNA chain formation. As a result, rapidly dividing cancer cells are unable to multiply properly, which helps reduce cancer cell growth as part of a planned chemotherapy regimen. Cytosar Injection 1000 mg should be administered only by trained healthcare professionals in a hospital, cancer center, or specialist-supervised clinical environment. Depending on the formulation and treatment protocol, Cytarabine may be administered by: Intravenous injection Intravenous infusion Subcutaneous injection Intrathecal administration, only when the correct preservative-free formulation is used and prescribed The exact dose is not fixed for every patient. It depends on: Type of cancer Stage and treatment protocol Body surface area Age and body weight Blood count status Liver and kidney function Previous chemotherapy history Combination medicines being used Specialist treatment plan Why Choose Primecare Impex Primecare Impex provides structured medicine information support for international healthcare-related enquiries. The focus is on product profile clarity, documentation awareness, and responsible communication for regulated pharmaceutical products. Primecare Impex Highlights Pharmaceutical exporter from India Product information support for oncology medicines Focus on regulated medicine documentation Clear product profile details Professional communication support Guidance on packaging, strength, and product identity Compliance-aware approach for destination country requirements Contact Primecare Impex – Pharmaceutical Exporter from India Company Name: Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Cytosar Injection 1000 mg is an anticancer injection containing Cytarabine 1000 mg in 10 ml. 2. What is the use of Cytarabine 1000 mg injection? Cytarabine is used in selected chemotherapy protocols, especially for acute leukemia treatment under specialist supervision. 3. Is Cytosar Injection 1000 mg used for cancer? Yes, it is an anticancer medicine used in specific leuke

Cytaneon Injection 1000 mg – Cytarabine 1000 mg/10 ml Anticancer Injection Information | Primecare Impex Learn about Cytaneon Injection 1000 mg, containing Cytarabine 1000 mg/10 ml, an anticancer medicine used in leukemia treatment protocols under specialist medical supervision. Explore indications, mechanism, administration guidance, safety monitoring, storage, documentation, and Primecare Impex contact details. Cytaneon Injection 1000 mg – Cytarabine 1000 mg/10 ml Anticancer Injection for Oncology Treatment Support Product Profile: Understanding Cytaneon Injection 1000 mg Cytaneon Injection 1000 mg contains Cytarabine 1000 mg/10 ml, an anticancer chemotherapy medicine used in oncology care. Cytarabine belongs to the antimetabolite class of medicines and is mainly used in treatment protocols for blood cancers such as acute leukemia, as decided by an oncologist. Cytaneon Injection is not a general-use medicine and should never be self-administered. It must be handled, prescribed, prepared, and administered only by trained healthcare professionals in a hospital, oncology center, or licensed medical setting. Product Profile: Understanding Cytaneon Injection 1000 mg Cytaneon Injection 1000 mg contains Cytarabine 1000 mg/10 ml, an anticancer chemotherapy medicine used in oncology care. Cytarabine belongs to the antimetabolite class of medicines and is mainly used in treatment protocols for blood cancers such as acute leukemia, as decided by an oncologist. Cytaneon Injection is not a general-use medicine and should never be self-administered. It must be handled, prescribed, prepared, and administered only by trained healthcare professionals in a hospital, oncology center, or licensed medical setting. Cytarabine is used in oncology treatment plans where doctors require an antimetabolite chemotherapy agent. It is commonly associated with leukemia treatment protocols, especially acute myeloid leukemia and other acute leukemia regimens as determined by a specialist. The use of Cytaneon Injection 1000 mg depends on several clinical factors, including: Patient diagnosis Cancer type and stage Body surface area and overall health condition Kidney and liver function Blood count status Previous chemotherapy history Combination medicines used in the protocol Hospital or oncology-center treatment guidelines Cytaneon Injection should only be used when prescribed by a qualified oncologist. Patients should not use this medicine without proper medical assessment, prescription, and monitoring. 2. Mechanism of Action: How Cytaneon Injection Works Cytaneon Injection contains Cytarabine, an antimetabolite chemotherapy medicine. Cytarabine works by interfering with DNA synthesis in rapidly dividing cells. Cancer cells grow and divide quickly, and Cytarabine helps slow or stop this abnormal cell multiplication as part of a planned chemotherapy regimen. In simple words, Cytarabine affects the ability of cancer cells to copy their genetic material during cell division. This makes it useful in specific blood cancer treatment protocols where rapidly dividing abnormal cells need to be controlled. Because it can also affect normal fast-growing cells, careful monitoring is required. This is why blood tests, infection monitoring, liver function checks, kidney function checks, and specialist supervision are important during treatment. Cytaneon Injection 1000 mg is administered only by trained healthcare professionals. The exact dose, route, dilution, infusion duration, and treatment schedule must be decided by the treating oncologist. Cytarabine may be used through different routes depending on the prescribed treatment protocol, such as: Intravenous injection or infusion Subcutaneous administration in selected regimens Intrathecal use only when a suitable preservative-free preparation is prescribed and administered by specialists Why Choose Primecare Impex Primecare Impex is an India-based pharmaceutical exporter, supplier, and distributor providing product information and regulated medicine supply support for international requirements. Why customers contact Primecare Impex: Product information support Export documentation support Oncology medicine sourcing guidance Professional communication India-based pharmaceutical supply network Support for country-wise documentation requirements Assistance with product details, packing, and availability updates Primecare Impex supports responsible medicine supply and recommends that all anticancer medicines be used only under proper medical prescription and supervision. Contact Primecare Impex – Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Cytarabine 1000 mg injection product information Cytarabine 1000 mg/10 ml injection details Cytaneon Injection 1000 mg information Cytarabine injection for leuke

Learn about Cyphos Injection 500 MG, a Cyclophosphamide Injection used in oncology care under medical supervision. Read its clinical uses, mechanism, safety monitoring, storage, handling, and regulatory information. Product Headline Cyphos Injection 500 MG – Cyclophosphamide Injection for Specialist Oncology Treatment Support Cyphos Injection 500 MG Product Name: Cyphos Injection 500 MG Generic Name: Cyclophosphamide Injection 500 MG Packing Size: 1 Vial Therapeutic Category: Anti-Cancer Medicine / Cytotoxic Chemotherapy Dosage Form: Injection Use: Used in selected cancer treatment protocols under specialist medical supervision Cyphos Injection 500 MG contains Cyclophosphamide, a chemotherapy medicine that belongs to the group of medicines known as alkylating agents. It is used in different oncology treatment plans where a qualified oncologist decides that cyclophosphamide is suitable for the patient’s condition. Cyclophosphamide is a powerful medicine and should never be used without a doctor’s prescription, hospital guidance, and proper monitoring. The medicine may be given alone or as part of combination chemotherapy depending on the cancer type, treatment stage, patient health condition, and medical protocol. Cyphos Injection 500 MG may be used by healthcare professionals in selected treatment protocols for certain cancers. Cyclophosphamide is commonly known in oncology practice for its role in managing conditions such as: Lymphomas Leukemias Breast cancer Ovarian cancer Multiple myeloma Some pediatric cancers Certain solid tumors Some immune-related medical conditions when prescribed by a specialist The exact use depends on the patient’s diagnosis, stage of disease, blood reports, organ function, and the oncologist’s treatment plan. Important Patient Note Cyphos Injection 500 MG is not a general-use medicine. It is a cytotoxic chemotherapy drug and should be administered only in a hospital, cancer center, oncology clinic, or properly equipped healthcare setting. How Cyclophosphamide Works Cyclophosphamide works by interfering with the DNA of rapidly dividing cells. Cancer cells grow and divide faster than many normal cells. Cyclophosphamide forms active metabolites in the body that can damage cancer-cell DNA and reduce the ability of cancer cells to multiply. In simple words: The medicine enters the body through injection. It is converted into active forms inside the body. These active forms affect the DNA of rapidly dividing cells. This helps slow or stop the growth of sensitive cancer cells. The treatment response depends on cancer type, combination therapy, and patient condition. Because normal cells such as blood-forming cells, hair follicles, and digestive tract cells can also divide quickly, side effects can occur. This is why regular medical monitoring is very important. Cyphos Injection 500 MG should be administered only by trained healthcare professionals. The dose is not fixed for every patient. It depends on several medical factors, including: Cancer type Body weight or body surface area Kidney and liver function Blood count reports Previous chemotherapy history Combination medicines used Treatment cycle schedule Patient tolerance and side effects Step-by-Step Medical Administration Overview Step 1: Doctor Evaluation Before treatment, the oncologist reviews the diagnosis, previous treatment history, blood reports, kidney function, liver function, and overall health status. Step 2: Prescription-Based Treatment Plan The doctor decides whether Cyclophosphamide Injection 500 MG is appropriate and whether it should be given alone or with other chemotherapy medicines. Step 3: Pre-Treatment Checks Healthcare staff may check blood counts, hydration status, kidney function, infection signs, and other risk factors before administration. Step 4: Preparation by Trained Staff The injection should be prepared in a controlled healthcare environment using proper cytotoxic handling procedure Why Choose Primecare Impex – Informational Support for Oncology Medicine Awareness Primecare Impex provides product information support for healthcare-related enquiries and helps users understand oncology medicine profiles, documentation awareness, storage guidance, and responsible medicine information. Primecare Impex Focus Areas Oncology medicine information support Product profile guidance Storage and handling awareness Documentation awareness Global healthcare enquiry support Clear communication for regulated medicines Responsible information sharing for prescription-based products Primecare Impex encourages safe, legal, prescription-based, and doctor-supervised use of oncology medicines. Contact Primecare Impex Primecare Impex — Pharmaceutical Exporter from India 🌐 Website: www.medicineexporterfromindia.com 📧 Email: raakeshkashiwar@gmail.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 9673008130 📲 WhatsApp Link: https://wa.me/919673008130

Learn about Cyclophosphamide Injection 500 MG, an anticancer chemotherapy medicine used under medical supervision. Explore indications, mechanism of action, administration guidance, safety monitoring, storage, compliance documents, and contact details for Primecare Impex. Cyclophosphamide Injection 500 MG – Anticancer Chemotherapy Medicine for Specialist Oncology Care Product Profile: Understanding Cyclophosphamide Injection 500 MG Product Name: Cyclophosphamide Injection 500 MG Strength: 500 MG Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Chemotherapy Medicine Dosage Form: Injection Use: Anticancer medicine used only under medical supervision Administration: To be given by a qualified healthcare professional only Prescription Status: Prescription oncology medicine Cyclophosphamide Injection 500 MG is a chemotherapy medicine used in cancer treatment protocols as advised by oncologists. It belongs to a class of medicines known as alkylating agents. These medicines work by interfering with the growth and multiplication of abnormal cells. Because Cyclophosphamide is a potent cytotoxic medicine, it must be used only under the supervision of trained medical professionals in a hospital, cancer center, or approved clinical setting. Cyclophosphamide may be used alone in some medical situations, but it is commonly included in combination chemotherapy regimens depending on the type of cancer, stage of disease, patient health status, previous treatment history, and physician Cyclophosphamide Injection 500 MG is used in oncology care for selected cancers and immune-related conditions when prescribed by a qualified specialist. The exact indication, dose, treatment schedule, and combination therapy depend on medical evaluation. Common Oncology-Related Uses May Include: 1. Lymphomas Cyclophosphamide may be used in treatment regimens for certain types of lymphoma. It is often combined with other anticancer medicines depending on the protocol selected by the oncologist. 2. Leukemia Treatment Protocols In some cases, Cyclophosphamide may be part of treatment planning for blood-related cancers, including selected leukemia protocols. 3. Breast Cancer Regimens Cyclophosphamide may be used as part of combination chemotherapy in certain breast cancer treatment plans. 4. Ovarian Cancer Treatment Oncologists may include Cyclophosphamide in specific chemotherapy regimens depending on patient condition and treatment goals. 5. Multiple Myeloma and Other Malignancies Cyclophosphamide may be considered in some treatment combinations for multiple myeloma and other cancers based on specialist guidance. How Cyclophosphamide Works Cyclophosphamide is classified as an alkylating agent. It affects rapidly dividing cells by damaging cellular DNA. Cancer cells divide quickly, and Cyclophosphamide interferes with their ability to multiply and survive. Step-by-Step Mechanism: Step 1: Medicine Enters the Body After administration by a trained healthcare professional, Cyclophosphamide is absorbed into the bloodstream. Step 2: Activation in the Body Cyclophosphamide is a prodrug, meaning it requires activation inside the body before it becomes fully active. Step 3: DNA Interference The active metabolites of Cyclophosphamide interact with DNA inside cells. This disrupts DNA replication and cell division. Step 4: Cancer Cell Growth Slows Because cancer cells often divide rapidly, Cyclophosphamide can help reduce abnormal cell multiplication. Step 5: Treatment Response Is Monitored Doctors monitor patient response through clinical examination, blood tests, imaging, and other disease-specific evaluations. Step 1: Medical Evaluation Before treatment, the doctor reviews diagnosis, treatment goal, blood test reports, kidney function, liver function, current medicines, infection history, and overall health. Contact Primecare Impex — Pharmaceutical Support from India For product information, documentation support, and regulated medicine inquiries, contact Primecare Impex. 🌐 Website: www.medicineexporterfromindia.com 📧 Email: raakeshkashiwar@gmail.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 9673008130 📲 WhatsApp Link: https://wa.me/919673008130 Why Choose Primecare Impex Primecare Impex provides pharmaceutical product information and support for regulated medicine requirements with a focus on documentation, product clarity, and responsible communication. Primecare Impex Highlights Clear product information Support for documentation requirements Focus on regulated pharmaceutical handling Responsive communication Product details shared with transparency Guidance for prescription and compliance requirements Responsible approach for oncology medicines Support for international medicine-related inquiries Primecare Impex encourages responsible use of prescription medicines and recommends that Cyclophosphamide Injection 500 MG be used only under licensed medical supervision.

Cisplatin Injection 10 MG, also known as Cizcan Injection 10 MG, is an anti-cancer medicine used under medical supervision for specific cancer treatment protocols. Learn about uses, mechanism, administration, safety, storage, documentation, and availability through Primecare Impex, pharmaceutical exporter from India. Cizcan Injection 10 MG Cizcan Injection 10 MG contains Cisplatin, a platinum-based anti-cancer medicine used in oncology treatment. It belongs to a class of chemotherapy medicines that are prescribed by qualified oncologists for selected cancer conditions. Cisplatin Injection is generally administered in a hospital, oncology clinic, or cancer-care center by trained healthcare professionals. Product Name: Cizcan Injection 10 MG Generic Name: Cisplatin Injection 10 MG Strength: 10 MG Packing Size: 1 Vial Therapeutic Category: Anti-Cancer Medicine / Oncology Medicine Dosage Form: Injection Route of Administration: Intravenous use under medical supervision Use: Anti-cancer medicine Supplier: Primecare Impex Business Type: Exporter | Supplier | Distributor from India Cisplatin Injection 10 MG is used in oncology treatment plans where a doctor recommends platinum-based chemotherapy. It may be used alone or in combination with other anti-cancer medicines depending on the patient’s diagnosis, cancer stage, treatment response, body condition, and medical history. Cisplatin is commonly associated with treatment protocols for selected types of cancers such as: Testicular cancer Ovarian cancer Bladder cancer Lung cancer Head and neck cancer Cervical cancer Other solid tumors as decided by an oncologist The final decision for using Cisplatin Injection 10 MG should always be made by a qualified cancer specialist. The medicine must be given only in a healthcare facility where proper monitoring, emergency support, and diagnostic facilities are available. How Cisplatin Works Cisplatin is a platinum-based chemotherapy medicine. It works by interfering with the DNA structure inside rapidly dividing cancer cells. Cancer cells divide and multiply quickly, and Cisplatin helps damage their DNA so that the cancer cells cannot grow and reproduce normally. In simple terms: Cisplatin enters the cancer cell. It binds with DNA inside the cell. This DNA damage blocks cell division. The damaged cancer cell may stop growing or die. The treatment effect depends on cancer type, stage, and overall therapy plan. Because Cisplatin may also affect some healthy fast-growing cells, side effects can occur. This is why regular medical monitoring is essential during treatment. Cizcan Injection 10 MG should be administered only by trained medical staff in a hospital or oncology-care setting. The dose and schedule depend on: Type of cancer Body surface area or body weight Kidney function Blood test results Previous chemotherapy history Other medicines being used Patient’s hydration status Step 1: Prescription Review The oncologist reviews diagnosis, previous treatment history, lab reports, kidney function, liver function, and treatment goals. Step 2: Patient Evaluation Before administration, the healthcare team may check blood counts, kidney function, electrolytes, hearing condition, hydration level, and general fitness for chemotherapy. Step 3: Hydration Support Cisplatin treatment often requires hydration support before and after administration to help reduce kidney-related risks. The hydration plan is decided by the treating doctor. Step 4: Medicine Preparation The vial should be handled and prepared by trained oncology staff using safe chemotherapy handling procedures. Step 5: Intravenous Administration Cisplatin Injection is given through a vein as an infusion. The infusion time and dilution method depend on the treatment protocol and hospital guidelines. Why Choose Primecare Impex? Primecare Impex is a pharmaceutical exporter from India offering product support for oncology medicines and other healthcare products. The company focuses on professional communication, export documentation support, and product availability assistance for international requirements. Primecare Impex Highlights Pharmaceutical exporter from India Oncology medicine product support Export documentation assistance Clear product communication Support for international enquiries Professional handling of medicine-related requests Guidance on packing, product details, and availability Assistance for regulated supply channels Contact Primecare Impex – Pharmaceutical Exporter from India For product enquiry, availability, documentation, and export-related support, contact Primecare Impex. Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Learn about Ciplatin Injection 50 mg/50 ml, also known as Cytoplatin Injection, a cisplatin-based anti-cancer medicine used under oncology supervision. Read indications, mechanism, administration, safety, storage, and compliance information. Ciplatin Injection 50 mg/50 ml – Cisplatin-Based Anti-Cancer Injection for Oncology Care Product Profile: Understanding Ciplatin Injection 50 mg/50 ml Product Name: Ciplatin Injection 50 mg / Cytoplatin Injection 50 mg/50 ml Generic Composition: Cisplatin Injection Strength: 50 mg/50 ml Packing Size: 1 Vial Therapeutic Category: Anti-Cancer / Chemotherapy Medicine Dosage Form: Injectable solution for intravenous use Use: Used in cancer treatment under the supervision of a qualified oncologist Ciplatin Injection 50 mg/50 ml contains cisplatin, a platinum-based chemotherapy medicine. It is used in oncology treatment protocols for certain cancers as decided by a cancer specialist. Cisplatin is not a general-use medicine and should only be administered in a hospital, oncology center, or approved clinical setting. Cisplatin treatment requires proper diagnosis, patient evaluation, kidney function monitoring, blood test monitoring, hydration support, and medical supervision. Cisplatin is administered by slow intravenous infusion and should not be given as a rapid IV injection. Ciplatin Injection 50 mg/50 ml may be used as part of chemotherapy treatment plans for different cancer types, depending on diagnosis, stage, patient condition, and oncologist recommendation. Cisplatin may be used alone or in combination with other anti-cancer medicines for cancers such as ovarian, testicular, bladder, lung, head and neck, gastric, and other cancers where platinum-based chemotherapy is clinically suitable. Ciplatin Injection should be used only when prescribed by a registered medical practitioner or oncologist. The dose, cycle frequency, infusion time, and supportive care plan are decided according to body surface area, kidney function, blood counts, cancer type, and treatment protocol. How Ciplatin Injection Works Ciplatin Injection contains cisplatin, a platinum-containing chemotherapy agent. Cisplatin works by interfering with the DNA structure inside rapidly dividing cancer cells. This DNA damage prevents cancer cells from multiplying properly and can lead to cancer cell death. In simple terms, cisplatin targets fast-growing cancer cells by disturbing their DNA repair and replication process. Because some normal cells also divide quickly, side effects may occur in blood cells, hair follicles, digestive lining, kidneys, nerves, and hearing-related structures. Step 1: Medical Evaluation Before treatment, the oncology team may check: Kidney function Liver function Complete blood count Electrolytes Hearing status when required Current medicines and allergies Previous chemotherapy history Cisplatin can cause serious kidney-related side effects, so doctors commonly monitor kidney function before and during treatment. Step 2: Treatment Planning The oncologist decides the cisplatin dose based on: Cancer type Treatment protocol Patient’s height and weight Body surface area Kidney function Previous chemotherapy exposure General health condition Step 3: Pre-Hydration and Supportive Medicines Patients may receive IV fluids before and after cisplatin to support kidney safety. Anti-nausea medicines may also be given because cisplatin can cause nausea and vomiting. Ciplatin Injection is administered by slow intravenous infusion. It should not be given as a rapid IV injection. Aluminum-containing needles or IV sets should not be used with cisplatin because aluminum can react with the medicine. Why Choose Primecare Impex Primecare Impex provides pharmaceutical product information with a focus on quality, documentation, compliance, and safe medicine handling. Primecare Impex Highlights Pharmaceutical exporter from India Focus on oncology and specialty medicines Product documentation support where applicable Professional communication Compliance-focused medicine supply approach Support for regulated pharmaceutical requirements Contact Primecare Impex – Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Do not self-administer this injection. Do not use without a valid prescription. Do not change dose or schedule without medical advice. Inform the doctor about kidney disease, hearing issues, pregnancy, breastfeeding, or current medicines. Report fever, chills, breathing difficulty, severe vomiting, low urine output, hearing changes, or unusual bleeding immediately.

Celzar Injection 1000 MG contains Gemcitabine 1000 MG, an anticancer chemotherapy medicine used under oncology supervision for selected cancers. Learn indications, mechanism, administration, safety, storage, and documentation support from Primecare Impex. Celzar Injection 1000 MG – Gemcitabine Injection 1000 MG for Oncology Treatment Support Product Snapshot Product Name: Celzar Injection 1000 MG Generic Name: Gemcitabine Injection 1000 MG Packing Size: 1 Vial Therapeutic Use: Anticancer medicine Dosage Form: Injection / IV infusion preparation Use Category: Oncology / Chemotherapy medicine Administration: Only by qualified healthcare professionals in a hospital, oncology center, or supervised clinical setup Product Profile: Understanding Celzar Injection 1000 MG Celzar Injection 1000 MG is a gemcitabine-based anticancer injection used in oncology treatment protocols. Gemcitabine belongs to a class of medicines known as antimetabolite chemotherapy agents. It is prescribed by oncologists for selected cancer conditions depending on the patient’s diagnosis, treatment stage, body surface area, blood counts, organ function, previous treatment history, and combination therapy plan. Celzar Injection 1000 MG is not a general-use medicine. It must not be used without a prescription, medical supervision, and proper oncology evaluation. The injection is commonly prepared and administered by trained medical staff through intravenous infusion. Because chemotherapy medicines can affect healthy cells along with cancer cells, patients receiving gemcitabine require regular monitoring, blood tests, and treatment-cycle review. Gemcitabine Injection 1000 MG may be used in cancer treatment plans where gemcitabine is medically appropriate. Depending on local regulatory approval and the oncologist’s protocol, gemcitabine may be used alone or in combination with other anticancer medicines. Common Oncology Areas Where Gemcitabine May Be Used Pancreatic Cancer Gemcitabine is widely known in oncology care as a chemotherapy option for locally advanced or metastatic pancreatic cancer. It may be used alone or with other agents depending on the treatment plan. Non-Small Cell Lung Cancer Gemcitabine may be used in combination regimens for selected cases of non-small cell lung cancer, especially where combination chemotherapy is recommended by the oncology team. Ovarian Cancer Gemcitabine may be used with platinum-based therapy such as carboplatin in selected ovarian cancer cases, especially in relapsed disease where the oncologist finds it suitable. Breast Cancer In some treatment protocols, gemcitabine may be used in combination with paclitaxel for selected advanced or metastatic breast cancer cases. Bladder Cancer Gemcitabine may also be used with cisplatin in selected locally advanced or metastatic bladder cancer treatment protocols. How Celzar Injection Works Celzar Injection 1000 MG contains gemcitabine, an antimetabolite chemotherapy medicine. Cancer cells grow and divide quickly. Gemcitabine interferes with the process of DNA synthesis inside rapidly dividing cells. Step-by-Step Action in the Body Step 1: Entry into the Cell After IV administration, gemcitabine enters cells and is converted into active forms inside the body. Step 2: Interference with DNA Building Blocks Cancer cells require DNA replication to multiply. Gemcitabine acts like a false building block and disrupts the DNA-making process. By interrupting DNA synthesis, gemcitabine may slow or stop the multiplication of sensitive cancer cells. Treatment Cycle Response Chemotherapy is usually given in cycles so that cancer cells are targeted while the body gets time to recover between doses. Because gemcitabine can also affect normal fast-growing cells, side effects may occur. This is why blood tests and clinical monitoring are required throughout therapy. Why Choose Primecare Impex Primecare Impex provides product information and documentation support for oncology medicines such as Celzar Injection 1000 MG. The focus is on genuine product details, correct strength information, professional communication, and support for prescription-based anticancer medicine requirements. Primecare Impex Highlights Pharmaceutical exporter from India Oncology medicine information support Product documentation assistance Clear communication for strength, packing, and product details Support for international medicine enquiry handling Professional coordination for prescription-based products Focus on safe, compliant, and responsible medicine information Contact Primecare Impex – Pharmaceutical Exporter from India For Celzar Injection 1000 MG product information, documentation support, and availability-related enquiry, contact Primecare Impex. Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Learn about Carboplatin Injection 150 MG, SYMCARBO 150 MG/15 ML, including clinical uses, mechanism of action, administration, safety monitoring, storage, and important oncology guidance. Carboplatin Injection 150 MG – SYMCARBO 150 MG/15 ML for Oncology Treatment Support Product Profile: Understanding SYMCARBO 150 MG/15 ML Product Name: Carboplatin Injection 150 MG Brand/Variant: SYMCARBO 150 MG/15 ML Packing Size: 1 Vial Dosage Form: Injection / Solution for IV Infusion Therapeutic Category: Anticancer Medicine / Platinum-Based Chemotherapy Use: Oncology treatment support under specialist supervision Carboplatin Injection 150 MG is an anticancer medicine used in chemotherapy treatment plans. It belongs to the platinum-containing class of chemotherapy medicines and is generally administered in hospital, oncology daycare, or cancer-care settings by trained medical professionals. SYMCARBO 150 MG/15 ML contains carboplatin, which is used as part of cancer treatment protocols depending on the patient’s diagnosis, body surface area, kidney function, blood count, previous treatment history, and oncologist’s treatment plan. This medicine is not for self-use. It must be prescribed, prepared, diluted, administered, and monitored by qualified healthcare professionals. Carboplatin Injection may be used alone or in combination with other anticancer medicines depending on the cancer type and treatment protocol. Carboplatin is commonly used in treatment plans for: Ovarian cancer Lung cancer treatment protocols Head and neck cancer protocols Bladder cancer protocols Germ cell tumor treatment plans Gynecologic oncology protocols Certain solid tumor chemotherapy regimens The exact use depends on the patient’s cancer stage, previous chemotherapy exposure, renal function, tolerance, and clinical decision by the oncologist. Carboplatin Injection 150 MG should be used only: With a valid prescription Under oncology supervision In a hospital or chemotherapy center With proper blood count monitoring With kidney function assessment With correct dilution and infusion procedure Patients should never self-administer Carboplatin Injection. How Carboplatin Works Carboplatin is a platinum-based chemotherapy medicine. It works by interfering with cancer-cell DNA. When the medicine enters the body, it forms platinum-DNA bonds that prevent cancer cells from copying and repairing their DNA properly. Because cancer cells divide rapidly, this DNA damage can slow cancer-cell growth and may lead to cancer-cell death. This is why carboplatin is used in many chemotherapy regimens for solid tumors. Simple Explanation Carboplatin works by: Entering the bloodstream through IV infusion Reaching cancer cells Binding to cancer-cell DNA Blocking DNA repair and replication Slowing or stopping cancer-cell multiplication 3. Administration and Dosing Guide Carboplatin Injection is given by intravenous infusion only. It should be administered by trained healthcare professionals in an oncology setup. Step-by-Step Administration Overview Step 1: Patient Evaluation Before treatment, the oncology team checks: Cancer diagnosis and stage Previous chemotherapy history Kidney function Complete blood count Platelet count Neutrophil count General health condition Body surface area or dosing formula requirement Step 2: Dose Calculation Carboplatin dosing is usually calculated by the treating oncologist. Dose may depend on: Renal function Target AUC Patient body parameters Treatment cycle Combination medicines Previous chemotherapy response Step 3: Dilution and Prepar Why Choose Primecare IMPEX Primecare IMPEX provides reliable information and support for oncology medicines, including anticancer injections used in hospital and specialist cancer-care settings. Key Reasons to Connect with Primecare IMPEX Oncology medicine product information support Prescription-based medicine handling guidance Export documentation support where applicable Professional communication for hospitals, clinics, and healthcare buyers Product details, packing information, and availability support Assistance with medicine category and compliance documentation Clear communication for international inquiries Support for regulated pharmaceutical supply requirements Primecare IMPEX follows responsible medicine communication and encourages use of Carboplatin Injection only under qualified medical supervision. Contact Primecare IMPEX — Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Learn about Carboplatin Injection 450 mg, its oncology use, mechanism of action, administration overview, safety monitoring, storage guidance, and regulatory documentation support from Primecare IMPEX. Carboplatin Injection 450 mg – Oncology Medicine Information by Primecare IMPEX Product Profile: Understanding Carboplatin Injection 450 mg Carboplatin Injection 450 mg is an anti-cancer chemotherapy medicine used in oncology treatment protocols under the supervision of qualified healthcare professionals. It belongs to the platinum-based chemotherapy class and is commonly used as part of cancer treatment plans where a physician determines suitability based on diagnosis, patient condition, kidney function, blood counts, and treatment history. Carboplatin is not a self-use medicine. It is administered in a hospital, cancer center, or supervised clinical setting. The medicine is generally given by intravenous infusion and requires professional monitoring before, during, and after administration. Product Overview Product Name: Carboplatin Injection 450 mg Generic Name: Carboplatin Strength: 450 mg Packing Size: 1 Vial Therapeutic Category: Anti-cancer medicine / Oncology chemotherapy Dosage Form: Injection Route of Administration: Intravenous infusion under medical supervision Use: Oncology treatment as prescribed by a qualified cancer specialist Carboplatin Injection 450 mg is used in oncology care as part of physician-directed chemotherapy protocols. It may be used alone or in combination with other anti-cancer medicines depending on cancer type, stage, patient tolerance, laboratory results, and treatment plan. A healthcare professional may consider Carboplatin in treatment protocols for selected cancers where platinum-based chemotherapy is clinically appropriate. The How Carboplatin Works Carboplatin is a platinum-based anti-cancer medicine. It works by interfering with cancer-cell DNA. When cancer-cell DNA is damaged, the cell may lose its ability to divide and multiply normally. This helps slow or stop the growth of cancer cells as part of a complete oncology treatment plan. Carboplatin is considered different from many general medicines because it acts directly on rapidly dividing cells. For this reason, it can also affect normal fast-growing cells in the body, which is why medical monitoring is very important. Carboplatin Injection 450 mg is administered by intravenous infusion. The exact dose is not fixed for every patient. It is calculated by the treating oncologist based on multiple patient-specific factors. Patient diagnosis Cancer type and stage Body size and treatment protocol Kidney function Blood-cell counts Previous chemotherapy exposure Other ongoing medicines Overall health condition Step 1: Prescription and Oncology Evaluation The oncologist confirms whether Carboplatin is suitable for the patient’s treatment plan. Step 2: Pre-Treatment Tests Blood counts, kidney function, liver function, and other relevant tests may be checked before treatment. Step 3: Dose Calculation The dose is calculated by the healthcare provider according to the approved protocol and patient condition. Step 4: Infusion Preparation The injection is prepared by trained healthcare staff using sterile handling procedures. Step 5: Intravenous Infusion Carboplatin is given into the bloodstream through IV infusion in a supervised medical setting. Step 6: Monitoring During Treatment The patient is observed for infusion reactions, tolerance, and immediate side effects. Step 7: Follow-Up Testing Blood counts and organ function may be monitored after treatment to guide the next cycle. Why Choose Primecare IMPEX Primecare IMPEX provides product-information support, documentation coordination, and export-related assistance for oncology medicines as per applicable regulations. The focus is on quality, compliance, transparency, and proper documentation. Primecare IMPEX Highlights Oncology medicine product-information support Export documentation assistance Batch and packing information support Professional communication Regulatory-focused approach Support for destination-wise document requirements Experienced supplier and distributor network from India Primecare IMPEX supports legal and compliant medicine supply only where all required licenses, prescriptions, permissions, and import approvals are available. Contact Primecare IMPEX – Pharmaceutical Exporter from India Business Name: Primecare IMPEX Business Type: Exporter | Supplier | Distributor Product: Carboplatin Injection 450 mg Packing Size: 1 Vial Category: Anti-cancer medicine / Oncology injection Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Canmab Injection 440 MG contains Trastuzumab (r-DNA origin), an anti-cancer medicine used under medical supervision for HER2-positive cancer treatment. Learn indications, mechanism, administration guidance, safety monitoring, storage, documentation, and product profile information from Primecare Impex. Canmab Injection 440 MG – Trastuzumab (r-DNA Origin) for HER2-Positive Cancer Treatment Support Canmab Injection 440 MG is a prescription anti-cancer medicine containing Trastuzumab (r-DNA origin). It belongs to a class of targeted cancer therapies known as HER2-targeted monoclonal antibodies. Canmab is used only under the supervision of a qualified oncologist and trained healthcare team. This medicine is generally associated with HER2-positive cancer treatment, especially where the cancer cells show overexpression of the HER2 receptor. HER2 testing is important before treatment decisions are made. Canmab Injection 440 MG is not a general-use medicine and should never be used without proper diagnosis, prescription, and medical monitoring. Basic Product Information Product Name: Canmab Injection 440 MG Generic Composition: Trastuzumab (r-DNA origin) Strength: 440 MG Packing Size: 1 Vial Therapeutic Category: Anti-cancer medicine Dosage Form: Injection / Infusion preparation Use: HER2-targeted oncology therapy under specialist supervision Administration: By trained healthcare professionals only Prescription Status: Prescription oncology medicine Trastuzumab is a targeted monoclonal antibody designed to act against cancer cells that overexpress the HER2 receptor. HER2 stands for Human Epidermal Growth Factor Receptor 2. In some cancers, HER2 activity may support faster cancer cell growth and survival. Trastuzumab works by targeting HER2-positive cells and helping reduce HER2-driven cancer progression. The term r-DNA origin means the medicine is produced using recombinant DNA biotechnology. This allows the development of a biologic medicine designed to target a specific cancer-related receptor pathway. Canmab Injection 440 MG may be used in oncology treatment plans where trastuzumab therapy is medically appropriate. The final decision depends on the patient’s diagnosis, HER2 test result, cancer stage, treatment history, organ function, and oncologist recommendation. HER2-Positive Breast Cancer Trastuzumab is widely associated with the management of HER2-positive breast cancer. It may be considered in early-stage, locally advanced, or metastatic disease depending on the treatment protocol and medical evaluation. HER2-Positive Metastatic Breast Cancer In advanced or metastatic HER2-positive breast cancer, trastuzumab may be used alone or with other anti-cancer medicines as decided by the oncology team. HER2-Positive Gastric or Gastroesophageal Junction Cancer Trastuzumab may also be used in selected HER2-positive stomach or gastroesophageal junction cancers, usually as part of a specialist-guided treatment plan. Combination Therapy Depending on the case, trastuzumab may be combined with chemotherapy, hormonal therapy, or other oncology medicines. Combination choice should always be made by a qualified oncologist. Canmab Injection 440 MG should not be used for self-treatment. It is not suitable for use without HER2 testing, prescription, cardiac assessment, infusion supervision, and continuous medical monitoring. How Canmab Works Canmab Injection 440 MG contains Trastuzumab, a HER2-targeted monoclonal antibody. Its action is based on targeting the HER2 receptor found on the surface of certain cancer cells. Step 1: HER2 Receptor Identification Some cancer cells have high HER2 receptor expression. These receptors may send growth signals that help cancer cells multiply. Step 2: Trastuzumab Binding Trastuzumab binds to the HER2 receptor on HER2-positive cancer cells. Step 3: Growth Signal Blocking By attaching to HER2, trastuzumab helps reduce HER2-related growth signaling. Step 4: Immune System Support Trastuzumab may also help the body’s immune system identify and attack HER2-positive cancer cells. Step 5: Treatment Response Monitoring The response is monitored through clinical evaluation, imaging, lab testing, and oncologist review. Why Choose Primecare Impex Primecare Impex provides product information and sourcing support for prescription oncology medicines with attention to documentation, handling requirements, and customer communication. Contact Primecare Impex — Pharmaceutical Exporter from India For Canmab Injection 440 MG product information, availability details, documentation support, and prescription-based medicine enquiry, contact Primecare Impex. Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130